Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000403

Chief Financial Officer sold 9,022 shares at an average $526.49 ($4,749,990)

  • Chief Financial Officer acquired 9,022 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hippel James · Chief Financial Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-01 Exercise or conversion : show line 1 in the form +8,822 $125.05 $1,103,191 19,577 D
2021-11-01 Sale : show line 2 in the form −3,566 $525.61 $1,874,318 16,011 D
2021-11-01 Sale : show line 3 in the form −2,880 $526.50 $1,516,321 13,131 D
2021-11-01 Sale : show line 4 in the form −1,433 $527.50 $755,903 11,698 D
2021-11-01 Sale : show line 5 in the form −943 $528.55 $498,427 10,755 D
2021-11-02 Exercise or conversion : show line 6 in the form +200 $125.05 $25,010 10,955 D
2021-11-02 Sale : show line 7 in the form −200 $525.10 $105,020 10,755 D
Open-market sales · 9,022 sh · avg $526.49 · $4,749,990

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-11-01 Exercise or conversion : show line 8 in the form Stock Options (Right to Buy) −8,822 47,589 D
2021-11-02 Exercise or conversion : show line 9 in the form Stock Options (Right to Buy) −200 47,389 D
Loading xslF345X03/edgar.xml…